However, the CETP inhibitor anacetrapib showed a highly significant but modest benefit for CVD in the REVEAL trial [ 13 ].
← all excerpts
The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction.
1
—
—